BTK and chronic myelogenous leukemia, BCR-ABL1 positive: Bcr-Abl is a tyrosine kinase that is known to play a major role in chronic myelogenous leukemia (CML), while Bruton’s tyrosine kinase (BTK) is implicated in B-cell malignancies (chronic lymphocytic leukemia and non-Hodgkin lymphomas).